gentaur logogentaur logo
x

PLAU / uPA Recombinant Protein

PLAU / uPA Recombinant Protein
PLAU / uPA Recombinant Protein

PLAU / uPA Recombinant Protein

1213.46 €

1213.46 €
In Stock
quantity
product details

Catalog number: 223 - 11-306

Product Category: Business & Industrial > Science & Laboratory

Supplier:

ProSciGentaur

Size: 0.05 mg

Related Products

uPA Recombinant Protein

91-360

uPA Recombinant Protein

Recombinant Human Urokinase-Type Plasminogen Activator is a serine protease, which specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. Urokinase-Type Plasminogen Activator is a potent marker of invasion and metastasis in many human cancers associated with breast, colon, stomach, bladder, brain, ovary and endometrium. Human Urokinase-Type Plasminogen Activator is initially synthesized as 431 amino acid precursor with a N-terminal signal peptide residues. The single chain molecule is processed into a disulfide-linked two-chain molecule. There exists two forms A chain, the long A chain contains an EGF-like domain that is responsible for binding of the uPA receptor. The B chain corresponds to the catalytic domain.

1423.44 €

Recombinant Human UPA

MBS7613929-005mg

Recombinant Human UPA

631.13 €

Recombinant Human UPA

MBS7613929-02mg

Recombinant Human UPA

1004.57 €

Urokinase - type plasminogen activator is also known as PLAU and UPA, a serine protease with an extremely limited substrate specificity, cleaving the sequence Cys – Pro – Gly - Arg560 - Val561 – Val – Gly – Gly – Cys in plasminogen to form plasmin. uPA is a potent marker of invasion and metastasis in a variety of human cancers associated with breast, stomach, colon, bladder, ovary, brain and endometrium.uPA and its receptor (uPAR) have been implicated in a broad spectrum of pathophysiological processes, including fibrinolysis, proteolysis, inflammation, atherogenesis and plaque destabilization, all of which are involved in the pathogenesis of MI (myocardial infarction).